|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The clinical decision support systems market was valued at approximately USD 1,450 million in 2020, and it is expected to reach USD 2,490 million by 2026, registering a CAGR of nearly 9.4% during the forecast period, 2021-2026.
Amid the COVID-19 pandemic, the health systems of countries are majorly dependent on online services. Through video calls, patients are getting appointments with doctors, which is helping in treating and monitoring the diseases, thereby propelling the clinical decision support systems market.
According to the World Ageing 2019 report, it was estimated that there were 703 million persons aged 65 years or over in the world in 2019. This group of the population mainly suffers from a lot of chronic diseases and needs regular health checks and treatments for the prevention of diseases. Based on the current situation across the world, there may be a lot of people, such as the elderly population and pregnant women, who may need health checks, but due to the COVID-19 outbreak across the world, the hospitals and clinics are unable to provide services. But several countries are increasingly providing online services, which is boosting the market.
Moreover, the healthcare facilities, such as hospitals, diagnostic centers, and clinics, are showing interest in clinical decision support systems in minimizing medication prescription errors, adverse drug events monitoring, and other medical errors.
The rising demand for reducing healthcare expenditure, need for improvement in the quality of care, and technological advancements in healthcare IT in hospitals are the major factors that are likely to boost the growth of the clinical decision support systems (CDSS) market.
Furthermore, according to the Organization for Economic Co-operation and Development (OECD) survey report, in 2018, the average per capita health expenditure was about USD 7,317 in Switzerland, USD 6,187 in Norway, and USD 5,005 in Australia. Due to high healthcare expenditure across the world, the rising demand to reduce healthcare expenditure has a positive impact on the market.
According to a study report by Elena Bellodi et. al. published in the BMC Medical Informatics and Decision Making 2017, the implementation of a clinical decision support system (CDSS) can have a positive impact on healthcare costs. Furthermore, the experience of using a clinical decision support system (CDSS) can also result in good practice to be implemented by other healthcare organizations as per the study conducted in Italy.
However, lack of trust in the systems, as CDSS are in the initial stages of development, lack of skilled labor, and suggestions from CDSS for unnecessary diagnostic testing hinder the market growth.
Scope of the Report
As per the scope of the report, clinical decision support systems refer to healthcare IT systems, designed specifically to assist clinical decision support for healthcare professionals and physicians. They include various tools that help enhance decision-making in the clinical workflow. Additionally, they provide computerized alerts and reminders to care providers and patients, clinical guidelines, focused patient data reports and summaries, diagnostic support, and documentation templates, among other tools.
The clinical decision support systems market is segmented by model (knowledge-based CDSS and non-knowledge CDSS), mode of delivery (cloud-based and on-premise), component (hardware, software, and services), product (integrated CDSS and standalone CDSS), application (medical diagnosis, alerts and reminders, prescription decision support, information retrieval, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
|By Mode of Delivery|
|Alerts and Reminders|
|Prescription Decision Support|
Key Market Trends
The Cloud-based Segment is Expected to Hold a Major Market Share
The increasing healthcare expenditure and adoption of cloud computing are the major drivers for the expansion of the cloud-based segment of the market. According to a survey by RightScale, nearly 95% of organizations run cloud-based applications. The hardware of electronic medical record (EMR) systems offered by different vendors is different. Hence, developing a standard CDSS software, which can run on multiple EMR systems, is a major challenge.
Furthermore, local knowledge management of CDSS may require extensive processing power and storage capacity, which can result in high operating costs. In contrast, cloud-based applications are operated in remote servers, and executing them does not require a large amount of computational power or large storage space in the user’s device.
Cloud-based applications do not depend on web browsers, which makes them inherently safer than web-based applications. In a cloud-based clinical decision support system, processing units are hosted on remote servers, which can be located in multiple data centers across the world, making them less vulnerable to cyberattacks. The increasing availability of cloud technology, owing to their benefit, is expected to drive the usage of cloud-based CDSS over the forecast period.
To understand key trends, Download Sample Report
North America is Expected to Hold a Significant Share in the Market in the Forecast Period
The clinical decision support systems (CDSS) market in North America is driven due to the rise in the technological advancement in CDSS, higher awareness rate among patients, and rising investments in healthcare IT solutions in the region are expected to boost the growth of the market during the forecast period.
As per the Centers for Disease Control and Prevention (CDC) 2019, 6 in 10 Americans have at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These chronic diseases are the leading causes of death and disability in the United States, and they are also a leading driver of healthcare costs. Moreover, according to the Organization for Economic Co-operation and Development (OECD) survey report, in 2019, the average per capita health expenditure in the United States was about USD 11,072.
In 2016, the Agency for Healthcare Research and Quality (AHRQ) launched a new initiative to disseminate and implement the findings of patient-centered outcomes research (PCOR) through clinical decision support (CDS). The two major goals of the initiative were to accelerate the movement of evidence into practice through CDS and to make CDS more shareable, standards-based, and publicly available. Such research efforts help engage patients, clinicians, provider organizations, and information technology professionals to improve decision-making in healthcare with the help of CDSS. These initiatives may fuel the growth of the CDSS market over the forecast period in North America.
To understand geography trends, Download Sample Report
The clinical decision support systems market has the presence of well-diversified international, regional, and local players. However, some big international players dominate the market owing to their brand image and market reach. The studied market is consolidated and competitive. The market players are continuously focusing on acquisitions, mergers, provision of customized solutions, and expansions in the untapped commercial markets. Moreover, companies are also investing huge amounts in developing new products and platforms, with enhanced and improved features as a part of the commercialization strategy.
In October 2020, WeHealth Digital Medicine, Servier Group's e-health business unit, and CureMatch, a leader in digital health precision medicine, announced that they had received CE Mark approval for Bionov. Bionov is a clinical decision support software platform that presents healthcare professionals with personalized single drug and combination drug treatment options based primarily on the molecular profile of their cancer patients.
In March 2020, IBM Watson Health and EBSCO Information Services announced a strategic collaboration aimed toward enhancing clinical decision support (CDS) and operations for healthcare providers and health systems. The companies are combining their respective solution suites into a single, high-value global solution called DynaMed and Micromedex With Watson. The combined solution suite is designed to bring together drug and disease content into a single source for evidence-based insights to help inform clinical decisions.
Table of Contents
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancement in Healthcare IT in Hospitals
4.2.2 Rising Demand to Reduce Healthcare Expenditure
4.2.3 Need for Improvement in Quality of Care and Reducing Human Errors
4.3 Market Restraints
4.3.1 Privacy and Data Security Concerns Related to Cloud-based CDSS
4.3.2 Lack of Skilled Professionals
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Model
5.1.1 Knowledge-based CDSS
5.1.2 Non-knowledge CDSS
5.2 By Mode of Delivery
5.3 By Component
5.4 By Product
5.4.1 Integrated CDSS
5.4.2 Standalone CDSS
5.5 By Application
5.5.1 Medical Diagnosis
5.5.2 Alerts and Reminders
5.5.3 Prescription Decision Support
5.5.4 Information Retrieval
5.5.5 Other Applications
5.6.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.6.4 Middle-East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle-East and Africa
5.6.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Cerner Corporation
6.1.4 Change Healthcare
6.1.6 Koninklijke Philips NV
6.1.7 Siemens Healthcare
6.1.8 Allscripts Healthcare Solutions Inc.
6.1.9 Wolters Kluwer Health
6.1.10 Mckesson Corporation
6.1.11 Zynx Health
6.1.12 Elsevier BV
6.1.13 NextGen Healthcare Inc.
6.1.14 Agfa-Gevaert Group
6.1.15 Athenahealth Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Clinical Decision Support Systems Market market is studied from 2018 - 2026.
What is the growth rate of Global Clinical Decision Support Systems Market?
The Global Clinical Decision Support Systems Market is growing at a CAGR of 9.4% over the next 5 years.
Which region has highest growth rate in Global Clinical Decision Support Systems Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Clinical Decision Support Systems Market?
North America holds highest share in 2020.
Who are the key players in Global Clinical Decision Support Systems Market?
Siemens Healthcare, Koninklijke Philips NV, IBM, Cerner Corporation, Change Healthcare are the major companies operating in Global Clinical Decision Support Systems Market.